Daiichi’s EZH Contender Moves Ahead In Leukemia/Lymphoma

Pivotal Trial The First For A Dual Inhibitor

 
• By Ian Haydock

Japanese company starts pivotal trial with novel molecule as it looks to build oncology presence.

Leukemia
Novel Daiichi ATL Candidate Enters Pivotal Trial • Source: Shutterstock

More from Anticancer

More from Therapy Areas